INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/20/2026
Back to search
Official data from USPTO
HALIOSEEK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HALIOSEEK
ST13
US500000079213961Class
5, 9, 10, 42, 44
Filing
79213961
Registration
5592381
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
08/20/2026
Trademark type
Word
Nice classes
5, 9, 10, 42, 44
Filing date
05/05/2017
Registration date
10/30/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2025
Last transaction
08/20/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
BROOKSHIRE, DAVID AARON
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Veracyte
HalioDx
Representatives
Kevin A. Thompson LADAS & PARRY LLP
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for use in vitro testingfor use in the clinical diagnosisprognosismonitoringprediction of response to treatments and on-going evaluationanalysis and study of a cancertumor or equivalent medical condition; chemical preparations for medical and pharmaceutical use for use in vitro testingfor use in the clinical diagnosticprognosismonitoringprediction of response to treatments and on-going evaluationanalysis and study of a cancertumor or equivalent medical condition; biological reagents for medical use for providing information on diagnostics or identification of biological systems; biological reagents for medical use providing information on diagnostics or identification of biological systems; immunological reagents for medical use; biological reagents for medical diagnosis; medical diagnostic kits comprising reagents and assays for testing tissue samples; biological reagents for medical research; biological reagents for medical use; biological reagents for clinical diagnosis
Class 9
Software for use in the clinical diagnosisprognosismonitoringprediction of response to treatments and on-going evaluationanalysis and study of a cancertumor or equivalent medical condition; application software in the field of biology for use in the clinical diagnosticprognosismonitoringprediction of response to treatments and on-going evaluationanalysis and study of a cancertumor or equivalent medical condition
Class 10
Medical apparatusinstruments and equipment for medical analysisnamely autostainersscanners; medical apparatus and instruments for providing information on diagnostics or identification of biological systemsmedical testing devices and diagnostic apparatus for detectinganalysing or assessing a cancertumor or equivalent medical condition; medical instruments for cancer cell detection
Class 42
Scientific research and development; clinical trial servicesintervening in the process of clinical trial services in assessment of biomarkers or signatures; tests in laboratoriesnamely analysis of biological mechanisms of actionsbiomarkers and signatures for research in biology purposes; development of quality control testing methods for others; researchdevelopmenttechnical designtestingconsultancy and analysis services in the field of immunology; research and development of antibodiestherapeutic productsvaccinesimmunotherapy treatments and diagnostic products; research services in the field of genome and immune index analysis; design and development of software in the field of biology
Class 44
Medical analysis servicesanalysis of tumorcancer or equivalent medical condition; medical assistance; heath care services; medical therapeutic services; medical diagnosticsdiagnostics in the field of medicine; genetic analysis services for medical purposes
Publications
History of USPTO decisions and trademark events.
41 publications found
INPC
INVALIDATION PROCESSED
08/20/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/16/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/21/2025
C71T
CANCELLED SECTION 71
05/16/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/30/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/12/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/01/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/07/2019
FIMP
FINAL DISPOSITION PROCESSED
02/07/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/30/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
10/30/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/14/2018
PUBO
PUBLISHED FOR OPPOSITION
08/14/2018
GPNX
NOTIFICATION PROCESSED BY IB
08/11/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/25/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/25/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/25/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/10/2018
RFNP
REFUSAL PROCESSED BY IB
06/23/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/13/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/12/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/12/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/03/2018
GNRT
NON-FINAL ACTION E-MAILED
05/03/2018
CNRT
NON-FINAL ACTION WRITTEN
05/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/21/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2018
ALIE
ASSIGNED TO LIE
02/19/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/12/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/31/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/31/2018
RFNT
REFUSAL PROCESSED BY IB
09/09/2017
MAFR
APPLICATION FILING RECEIPT MAILED
08/19/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/18/2017
RFRR
REFUSAL PROCESSED BY MPU
08/18/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/17/2017
CNRT
NON-FINAL ACTION WRITTEN
08/16/2017
DOCK
ASSIGNED TO EXAMINER
08/15/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/15/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/10/2017
Continuous trademark protection
Get notified about every new filing that threatens HALIOSEEK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.